Kisspeptin-10 50mg — Vial Spec, Reconstitution Math & COA

Overview and Purpose of the 50mg Kisspeptin-10 Packaging Spec

The 50mg Kisspeptin-10 vial specification is tailored specifically for laboratory environments running high-density assay plates, continuous cell line treatments, or multi-animal preclinical cohorts. Containing 50 milligrams of lyophilized peptide mass, this unit size allows research technicians to prepare high-concentration master stock solutions without the operational overhead of reconstituting multiple smaller vials.

While standard academic and screening protocols often utilize individual 10mg vials—such as those found on our standard Kisspeptin-10 product listing—large-scale institutional studies benefit from the logistical efficiency of a 50mg fill. Laboratories seeking bulk packaging options across our catalog can also utilize our wholesale program to coordinate bulk lot allocations, custom vial sizing, and specialized fill specifications. PX1 Research delivers lyophilized research compounds verified for structural identity and purity to support reproducible scientific inquiry.

Molecular Structure and Primary Mechanism of Action

Kisspeptin-10 is an endogenous decapeptide corresponding to residues 45–54 of the full-length KISS1 gene product (Kisspeptin-54). Structurally defined by the amino acid sequence Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 with a C-terminal carboxamide, Kisspeptin-10 represents the minimal sequence required for full biological activity at the G-protein coupled receptor GPR54 (KISS1R).

In preclinical models, Kisspeptin-10 acts as a potent endogenous agonist at GPR54. Binding of the decapeptide to GPR54 initiates a intracellular signaling cascade mediated by Gq/11 proteins, activating phospholipase C (PLC) and stimulating intracellular calcium mobilization alongside protein kinase C (PKC) phosphorylation. This pathway plays an essential upstream role in regulating the reproductive signaling axis, specifically driving the pulsatile release of Gonadotropin-Releasing Hormone (GnRH) from hypothalamic neurons into the hypophyseal portal system.

Preclinical Research Focus Areas & Experimental Context

In vitro and animal study literature identifies Kisspeptin-10 as a central regulator of reproductive signaling pathways. Researchers utilize this compound primarily to evaluate upstream control mechanisms governing luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion from the anterior pituitary gland.

Key experimental domains include investigating central pulse generator dynamics, mapping neuroendocrine feedback mechanisms, assessing puberty initiation cascades in rodent models, and evaluating downstream steroidogenesis. Because Kisspeptin-10 sits upstream of GnRH secretion, it serves as a critical biological tool for differentiating central hypothalamic signaling impairments from primary pituitary or gonadal target tissue non-responsiveness.

Comparative Analysis: Kisspeptin-10 vs. Downstream HPG Axis Regulators

Evaluating neuroendocrine control mechanisms requires selecting peptides that target distinct nodes along the HPG axis. While Kisspeptin-10 acts at the hypothalamic level via GPR54 activation to stimulate natural endogenous GnRH pulse generation, downstream secretagogues act directly upon pituitary gonadotropins.

For example, direct hypothalamic secretagogues such as Gonadorelin act directly on pituitary GnRH receptors to release gonadotropins without requiring intact kisspeptinergic neuron activation. Conversely, synthetic analogs like Triptorelin and Leuprolide exert potent, prolonged activation of GnRH receptors, which in chronic preclinical models leads to receptor desensitization and downstream suppression. Understanding these mechanistic differences allows investigators to select the precise node of intervention required for their experimental design.

Reconstitution Calculations for 50mg Stock Vials

Reconstituting a 50mg vial requires precise liquid handling calculations to achieve the target working concentration while maintaining full peptide solubility. Because 50mg represents a substantial peptide mass, researchers must select appropriate diluent volumes based on downstream microplate or microdispensing specs.

Below are standard concentration calculations when reconstituting a 50mg lyophilized Kisspeptin-10 vial: - **1.0 mL Diluent:** Yields a master stock concentration of 50.0 mg/mL (50,000 µg/mL). - **2.0 mL Diluent:** Yields a working stock concentration of 25.0 mg/mL (25,000 µg/mL). - **3.0 mL Diluent:** Yields a working stock concentration of 16.67 mg/mL (16,667 µg/mL). - **5.0 mL Diluent:** Yields a working stock concentration of 10.0 mg/mL (10,000 µg/mL).

For precise micro-molar dilutions, assay adjustments, or specific volumetric steps, researchers should consult our online reconstitution calculator to ensure accurate concentration mapping before preparing stock solutions.

Aliquot Planning, Solubilization, and Thermal Stability Protocols

Due to the hydrophobic characteristics of certain amino acid residues within the Kisspeptin-10 sequence (notably Trp, Phe, and Leu), proper reconstitution technique is essential. Diluent—such as sterile bacteriostatic water or sterile standard saline—should be introduced slowly down the interior glass wall of the vial under gentle vacuum release. Direct high-pressure jetting onto the lyophilized cake should be avoided to prevent protein shearing or foam formation.

Once dissolved, master stock solutions prepared from a 50mg vial should be immediately sub-aliquoted into single-use polypropylene microcentrifuge tubes. Repeated freeze-thaw cycles accelerate peptide degradation via hydrolysis and aggregation. Aliquots stored at -20°C maintain physical stability for short-term study blocks, whereas long-term preservation requires -80°C storage in sealed, low-binding containers.

Analytical Quality Assurance: HPLC, Mass Spectrometry, and COA Compliance

Preclinical experimental validity hinges on absolute compound purity and structural verification. PX1 Research enforces stringent analytical quality control protocols for every batch produced. Every lot undergoes independent, third-party laboratory verification within ISO 17025 accredited testing facilities.

Chemical verification includes High-Performance Liquid Chromatography (HPLC) to confirm high chemical purity (typically ≥98%) and Mass Spectrometry (MS) to verify precise molecular mass matching the theoretical weight of Kisspeptin-10 (~1302.45 Da). Additionally, bacterial endotoxin testing via Chromogenic LAL assays ensures that endotoxin levels remain below strict institutional thresholds suitable for sensitive cellular in vitro studies. Investigators can independently inspect lot-specific documentation anytime through our transparent COA portal.

Choosing the Right Format: 10mg vs. 50mg Vials for Lab Workflows

Selecting between a standard 10mg format and a bulk 50mg vial depends primarily on experimental scale, assay frequency, and handling capabilities. Small-scale screening projects or pilot in vitro studies often benefit from 10mg units, which minimize unused stock volume and reduce storage duration risks.

Conversely, high-throughput automated platforms, long-term animal cohort studies, or multi-departmental research units find the 50mg format significantly more cost-effective and operationally streamlined. Reviewing overall laboratory throughput across our catalog of all peptides allows lab procurement managers to optimize batch consistency and storage economics effectively.

PX1 Research Sourcing & Quality Commitments

PX1 Research is committed to supplying the scientific community with premium research compounds manufactured under rigorous quality standards. Operating within GMP-compliant synthesis facilities in the USA, we ensure that every peptide lot conforms to exact chemical specifications.

To support fast-paced research schedules, all orders ship same-day (Monday through Friday) directly from our centralized distribution facilities in California and Arizona. PX1 Research products are strictly supplied for laboratory research use only by qualified investigators.